Is Tetrahydrobiopterin Deficiency hereditary?

Tetrahydrobiopterin (BH4) deficiency is a rare genetic disorder that affects the production and recycling of a molecule called tetrahydrobiopterin. This molecule is essential for the proper functioning of several enzymes involved in the production of neurotransmitters, such as dopamine, serotonin, and norepinephrine.

BH4 deficiency is typically inherited in an autosomal recessive manner, which means that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. If both parents are carriers of the mutated gene, each of their children has a 25% chance of inheriting two copies and developing BH4 deficiency.

Genetic testing can be performed to identify mutations in the genes responsible for BH4 deficiency. There are several genes associated with this condition, including GCH1, PTS, PCBD1, and QDPR. Mutations in any of these genes can lead to BH4 deficiency.

It is important to note that not all individuals with BH4 deficiency have a family history of the condition. In some cases, the mutation may occur spontaneously in an individual with no family history of the disorder. This is known as a de novo mutation.

Early diagnosis of BH4 deficiency is crucial for appropriate management and treatment. Symptoms of BH4 deficiency can vary widely and may include neurological problems, developmental delays, movement disorders, and psychiatric symptoms. Genetic counseling is recommended for individuals with a family history of BH4 deficiency or those who have been diagnosed with the condition.